Global Meningococcal Vaccination Market Research Report 2025(Status and Outlook)
Meningococcal vaccination refers to immunization against Neisseria meningitidis, a bacterium that causes meningitis and septicemia, with vaccines developed to target the most common disease-causing serogroups (A, B, C, W, Y, and in some cases X). These vaccines are administered to prevent invasive meningococcal disease, which can lead to severe complications including permanent disabilities and high mortality rates, particularly in infants, adolescents, young adults, and immunocompromised individuals. The market includes polysaccharide, conjugate, and protein-based vaccines, with recommendations varying by region based on epidemiology, public health policies, and vaccine availability. Immunization schedules often target specific age groups and high-risk populations, and both routine childhood programs and outbreak response efforts drive demand.
The global Meningococcal Vaccination market size was estimated at USD 4215.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Meningococcal Vaccination market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Meningococcal Vaccination market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Meningococcal Vaccination market.
Global Meningococcal Vaccination Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
Biomed
Serum Institute of India
Market Segmentation (by Type)
Polysaccharide
Conjugate
Combination
Market Segmentation (by Application)
Pneumonia
Meningitis
Bacteremia
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Vaccination Market
Overview of the regional outlook of the Meningococcal Vaccination Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Vaccination, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Meningococcal Vaccination market size was estimated at USD 4215.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Meningococcal Vaccination market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Meningococcal Vaccination market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Meningococcal Vaccination market.
Global Meningococcal Vaccination Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
Biomed
Serum Institute of India
Market Segmentation (by Type)
Polysaccharide
Conjugate
Combination
Market Segmentation (by Application)
Pneumonia
Meningitis
Bacteremia
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Vaccination Market
Overview of the regional outlook of the Meningococcal Vaccination Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Vaccination, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Meningococcal Vaccination
1.2 Key Market Segments
1.2.1 Meningococcal Vaccination Segment by Type
1.2.2 Meningococcal Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccination Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Meningococcal Vaccination Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Meningococcal Vaccination Product Life Cycle
3.3 Global Meningococcal Vaccination Sales by Manufacturers (2020-2025)
3.4 Global Meningococcal Vaccination Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningococcal Vaccination Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Meningococcal Vaccination Market Competitive Situation and Trends
3.8.1 Meningococcal Vaccination Market Concentration Rate
3.8.2 Global 5 and 10 Largest Meningococcal Vaccination Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Meningococcal Vaccination Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Meningococcal Vaccination Market
5.7 ESG Ratings of Leading Companies
6 MENINGOCOCCAL VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccination Sales Market Share by Type (2020-2025)
6.3 Global Meningococcal Vaccination Market Size Market Share by Type (2020-2025)
6.4 Global Meningococcal Vaccination Price by Type (2020-2025)
7 MENINGOCOCCAL VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccination Market Sales by Application (2020-2025)
7.3 Global Meningococcal Vaccination Market Size (M USD) by Application (2020-2025)
7.4 Global Meningococcal Vaccination Sales Growth Rate by Application (2020-2025)
8 MENINGOCOCCAL VACCINATION MARKET SALES BY REGION
8.1 Global Meningococcal Vaccination Sales by Region
8.1.1 Global Meningococcal Vaccination Sales by Region
8.1.2 Global Meningococcal Vaccination Sales Market Share by Region
8.2 Global Meningococcal Vaccination Market Size by Region
8.2.1 Global Meningococcal Vaccination Market Size by Region
8.2.2 Global Meningococcal Vaccination Market Size Market Share by Region
8.3 North America
8.3.1 North America Meningococcal Vaccination Sales by Country
8.3.2 North America Meningococcal Vaccination Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Meningococcal Vaccination Sales by Country
8.4.2 Europe Meningococcal Vaccination Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Meningococcal Vaccination Sales by Region
8.5.2 Asia Pacific Meningococcal Vaccination Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Meningococcal Vaccination Sales by Country
8.6.2 South America Meningococcal Vaccination Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Meningococcal Vaccination Sales by Region
8.7.2 Middle East and Africa Meningococcal Vaccination Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MENINGOCOCCAL VACCINATION MARKET PRODUCTION BY REGION
9.1 Global Production of Meningococcal Vaccination by Region(2020-2025)
9.2 Global Meningococcal Vaccination Revenue Market Share by Region (2020-2025)
9.3 Global Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Meningococcal Vaccination Production
9.4.1 North America Meningococcal Vaccination Production Growth Rate (2020-2025)
9.4.2 North America Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Meningococcal Vaccination Production
9.5.1 Europe Meningococcal Vaccination Production Growth Rate (2020-2025)
9.5.2 Europe Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Meningococcal Vaccination Production (2020-2025)
9.6.1 Japan Meningococcal Vaccination Production Growth Rate (2020-2025)
9.6.2 Japan Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Meningococcal Vaccination Production (2020-2025)
9.7.1 China Meningococcal Vaccination Production Growth Rate (2020-2025)
9.7.2 China Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Meningococcal Vaccination Product Overview
10.1.3 GlaxoSmithKline Meningococcal Vaccination Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 JN-International Medical
10.2.1 JN-International Medical Basic Information
10.2.2 JN-International Medical Meningococcal Vaccination Product Overview
10.2.3 JN-International Medical Meningococcal Vaccination Product Market Performance
10.2.4 JN-International Medical Business Overview
10.2.5 JN-International Medical SWOT Analysis
10.2.6 JN-International Medical Recent Developments
10.3 Novartis International
10.3.1 Novartis International Basic Information
10.3.2 Novartis International Meningococcal Vaccination Product Overview
10.3.3 Novartis International Meningococcal Vaccination Product Market Performance
10.3.4 Novartis International Business Overview
10.3.5 Novartis International SWOT Analysis
10.3.6 Novartis International Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Meningococcal Vaccination Product Overview
10.4.3 Sanofi Meningococcal Vaccination Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Pfizer
10.5.1 Pfizer Basic Information
10.5.2 Pfizer Meningococcal Vaccination Product Overview
10.5.3 Pfizer Meningococcal Vaccination Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Baxter International
10.6.1 Baxter International Basic Information
10.6.2 Baxter International Meningococcal Vaccination Product Overview
10.6.3 Baxter International Meningococcal Vaccination Product Market Performance
10.6.4 Baxter International Business Overview
10.6.5 Baxter International Recent Developments
10.7 Biomed
10.7.1 Biomed Basic Information
10.7.2 Biomed Meningococcal Vaccination Product Overview
10.7.3 Biomed Meningococcal Vaccination Product Market Performance
10.7.4 Biomed Business Overview
10.7.5 Biomed Recent Developments
10.8 Serum Institute of India
10.8.1 Serum Institute of India Basic Information
10.8.2 Serum Institute of India Meningococcal Vaccination Product Overview
10.8.3 Serum Institute of India Meningococcal Vaccination Product Market Performance
10.8.4 Serum Institute of India Business Overview
10.8.5 Serum Institute of India Recent Developments
11 MENINGOCOCCAL VACCINATION MARKET FORECAST BY REGION
11.1 Global Meningococcal Vaccination Market Size Forecast
11.2 Global Meningococcal Vaccination Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Vaccination Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Vaccination Market Size Forecast by Region
11.2.4 South America Meningococcal Vaccination Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Meningococcal Vaccination by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Meningococcal Vaccination Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Meningococcal Vaccination by Type (2026-2033)
12.1.2 Global Meningococcal Vaccination Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Meningococcal Vaccination by Type (2026-2033)
12.2 Global Meningococcal Vaccination Market Forecast by Application (2026-2033)
12.2.1 Global Meningococcal Vaccination Sales (K MT) Forecast by Application
12.2.2 Global Meningococcal Vaccination Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Meningococcal Vaccination
1.2 Key Market Segments
1.2.1 Meningococcal Vaccination Segment by Type
1.2.2 Meningococcal Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccination Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Meningococcal Vaccination Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Meningococcal Vaccination Product Life Cycle
3.3 Global Meningococcal Vaccination Sales by Manufacturers (2020-2025)
3.4 Global Meningococcal Vaccination Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningococcal Vaccination Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Meningococcal Vaccination Market Competitive Situation and Trends
3.8.1 Meningococcal Vaccination Market Concentration Rate
3.8.2 Global 5 and 10 Largest Meningococcal Vaccination Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Meningococcal Vaccination Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Meningococcal Vaccination Market
5.7 ESG Ratings of Leading Companies
6 MENINGOCOCCAL VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccination Sales Market Share by Type (2020-2025)
6.3 Global Meningococcal Vaccination Market Size Market Share by Type (2020-2025)
6.4 Global Meningococcal Vaccination Price by Type (2020-2025)
7 MENINGOCOCCAL VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccination Market Sales by Application (2020-2025)
7.3 Global Meningococcal Vaccination Market Size (M USD) by Application (2020-2025)
7.4 Global Meningococcal Vaccination Sales Growth Rate by Application (2020-2025)
8 MENINGOCOCCAL VACCINATION MARKET SALES BY REGION
8.1 Global Meningococcal Vaccination Sales by Region
8.1.1 Global Meningococcal Vaccination Sales by Region
8.1.2 Global Meningococcal Vaccination Sales Market Share by Region
8.2 Global Meningococcal Vaccination Market Size by Region
8.2.1 Global Meningococcal Vaccination Market Size by Region
8.2.2 Global Meningococcal Vaccination Market Size Market Share by Region
8.3 North America
8.3.1 North America Meningococcal Vaccination Sales by Country
8.3.2 North America Meningococcal Vaccination Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Meningococcal Vaccination Sales by Country
8.4.2 Europe Meningococcal Vaccination Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Meningococcal Vaccination Sales by Region
8.5.2 Asia Pacific Meningococcal Vaccination Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Meningococcal Vaccination Sales by Country
8.6.2 South America Meningococcal Vaccination Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Meningococcal Vaccination Sales by Region
8.7.2 Middle East and Africa Meningococcal Vaccination Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MENINGOCOCCAL VACCINATION MARKET PRODUCTION BY REGION
9.1 Global Production of Meningococcal Vaccination by Region(2020-2025)
9.2 Global Meningococcal Vaccination Revenue Market Share by Region (2020-2025)
9.3 Global Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Meningococcal Vaccination Production
9.4.1 North America Meningococcal Vaccination Production Growth Rate (2020-2025)
9.4.2 North America Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Meningococcal Vaccination Production
9.5.1 Europe Meningococcal Vaccination Production Growth Rate (2020-2025)
9.5.2 Europe Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Meningococcal Vaccination Production (2020-2025)
9.6.1 Japan Meningococcal Vaccination Production Growth Rate (2020-2025)
9.6.2 Japan Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Meningococcal Vaccination Production (2020-2025)
9.7.1 China Meningococcal Vaccination Production Growth Rate (2020-2025)
9.7.2 China Meningococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Meningococcal Vaccination Product Overview
10.1.3 GlaxoSmithKline Meningococcal Vaccination Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 JN-International Medical
10.2.1 JN-International Medical Basic Information
10.2.2 JN-International Medical Meningococcal Vaccination Product Overview
10.2.3 JN-International Medical Meningococcal Vaccination Product Market Performance
10.2.4 JN-International Medical Business Overview
10.2.5 JN-International Medical SWOT Analysis
10.2.6 JN-International Medical Recent Developments
10.3 Novartis International
10.3.1 Novartis International Basic Information
10.3.2 Novartis International Meningococcal Vaccination Product Overview
10.3.3 Novartis International Meningococcal Vaccination Product Market Performance
10.3.4 Novartis International Business Overview
10.3.5 Novartis International SWOT Analysis
10.3.6 Novartis International Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Meningococcal Vaccination Product Overview
10.4.3 Sanofi Meningococcal Vaccination Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Pfizer
10.5.1 Pfizer Basic Information
10.5.2 Pfizer Meningococcal Vaccination Product Overview
10.5.3 Pfizer Meningococcal Vaccination Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Baxter International
10.6.1 Baxter International Basic Information
10.6.2 Baxter International Meningococcal Vaccination Product Overview
10.6.3 Baxter International Meningococcal Vaccination Product Market Performance
10.6.4 Baxter International Business Overview
10.6.5 Baxter International Recent Developments
10.7 Biomed
10.7.1 Biomed Basic Information
10.7.2 Biomed Meningococcal Vaccination Product Overview
10.7.3 Biomed Meningococcal Vaccination Product Market Performance
10.7.4 Biomed Business Overview
10.7.5 Biomed Recent Developments
10.8 Serum Institute of India
10.8.1 Serum Institute of India Basic Information
10.8.2 Serum Institute of India Meningococcal Vaccination Product Overview
10.8.3 Serum Institute of India Meningococcal Vaccination Product Market Performance
10.8.4 Serum Institute of India Business Overview
10.8.5 Serum Institute of India Recent Developments
11 MENINGOCOCCAL VACCINATION MARKET FORECAST BY REGION
11.1 Global Meningococcal Vaccination Market Size Forecast
11.2 Global Meningococcal Vaccination Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Vaccination Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Vaccination Market Size Forecast by Region
11.2.4 South America Meningococcal Vaccination Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Meningococcal Vaccination by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Meningococcal Vaccination Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Meningococcal Vaccination by Type (2026-2033)
12.1.2 Global Meningococcal Vaccination Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Meningococcal Vaccination by Type (2026-2033)
12.2 Global Meningococcal Vaccination Market Forecast by Application (2026-2033)
12.2.1 Global Meningococcal Vaccination Sales (K MT) Forecast by Application
12.2.2 Global Meningococcal Vaccination Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Vaccination Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Meningococcal Vaccination Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Meningococcal Vaccination Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Meningococcal Vaccination Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccination as of 2024)
Table 10. Global Market Meningococcal Vaccination Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Meningococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Meningococcal Vaccination Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Meningococcal Vaccination Sales by Type (K MT)
Table 26. Global Meningococcal Vaccination Market Size by Type (M USD)
Table 27. Global Meningococcal Vaccination Sales (K MT) by Type (2020-2025)
Table 28. Global Meningococcal Vaccination Sales Market Share by Type (2020-2025)
Table 29. Global Meningococcal Vaccination Market Size (M USD) by Type (2020-2025)
Table 30. Global Meningococcal Vaccination Market Size Share by Type (2020-2025)
Table 31. Global Meningococcal Vaccination Price (USD/KG) by Type (2020-2025)
Table 32. Global Meningococcal Vaccination Sales (K MT) by Application
Table 33. Global Meningococcal Vaccination Market Size by Application
Table 34. Global Meningococcal Vaccination Sales by Application (2020-2025) & (K MT)
Table 35. Global Meningococcal Vaccination Sales Market Share by Application (2020-2025)
Table 36. Global Meningococcal Vaccination Market Size by Application (2020-2025) & (M USD)
Table 37. Global Meningococcal Vaccination Market Share by Application (2020-2025)
Table 38. Global Meningococcal Vaccination Sales Growth Rate by Application (2020-2025)
Table 39. Global Meningococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 40. Global Meningococcal Vaccination Sales Market Share by Region (2020-2025)
Table 41. Global Meningococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 42. Global Meningococcal Vaccination Market Size Market Share by Region (2020-2025)
Table 43. North America Meningococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 44. North America Meningococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Meningococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 46. Europe Meningococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Meningococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Meningococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 49. South America Meningococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 50. South America Meningococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Meningococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Meningococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 53. Global Meningococcal Vaccination Production (K MT) by Region(2020-2025)
Table 54. Global Meningococcal Vaccination Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Meningococcal Vaccination Revenue Market Share by Region (2020-2025)
Table 56. Global Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GlaxoSmithKline Basic Information
Table 62. GlaxoSmithKline Meningococcal Vaccination Product Overview
Table 63. GlaxoSmithKline Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline SWOT Analysis
Table 66. GlaxoSmithKline Recent Developments
Table 67. JN-International Medical Basic Information
Table 68. JN-International Medical Meningococcal Vaccination Product Overview
Table 69. JN-International Medical Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. JN-International Medical Business Overview
Table 71. JN-International Medical SWOT Analysis
Table 72. JN-International Medical Recent Developments
Table 73. Novartis International Basic Information
Table 74. Novartis International Meningococcal Vaccination Product Overview
Table 75. Novartis International Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Novartis International Business Overview
Table 77. Novartis International SWOT Analysis
Table 78. Novartis International Recent Developments
Table 79. Sanofi Basic Information
Table 80. Sanofi Meningococcal Vaccination Product Overview
Table 81. Sanofi Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Pfizer Basic Information
Table 85. Pfizer Meningococcal Vaccination Product Overview
Table 86. Pfizer Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Baxter International Basic Information
Table 90. Baxter International Meningococcal Vaccination Product Overview
Table 91. Baxter International Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Baxter International Business Overview
Table 93. Baxter International Recent Developments
Table 94. Biomed Basic Information
Table 95. Biomed Meningococcal Vaccination Product Overview
Table 96. Biomed Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Biomed Business Overview
Table 98. Biomed Recent Developments
Table 99. Serum Institute of India Basic Information
Table 100. Serum Institute of India Meningococcal Vaccination Product Overview
Table 101. Serum Institute of India Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Serum Institute of India Business Overview
Table 103. Serum Institute of India Recent Developments
Table 104. Global Meningococcal Vaccination Sales Forecast by Region (2026-2033) & (K MT)
Table 105. Global Meningococcal Vaccination Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. North America Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (K MT)
Table 107. North America Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Europe Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (K MT)
Table 109. Europe Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Asia Pacific Meningococcal Vaccination Sales Forecast by Region (2026-2033) & (K MT)
Table 111. Asia Pacific Meningococcal Vaccination Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (K MT)
Table 113. South America Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Middle East and Africa Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (Units)
Table 115. Middle East and Africa Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 116. Global Meningococcal Vaccination Sales Forecast by Type (2026-2033) & (K MT)
Table 117. Global Meningococcal Vaccination Market Size Forecast by Type (2026-2033) & (M USD)
Table 118. Global Meningococcal Vaccination Price Forecast by Type (2026-2033) & (USD/KG)
Table 119. Global Meningococcal Vaccination Sales (K MT) Forecast by Application (2026-2033)
Table 120. Global Meningococcal Vaccination Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Vaccination Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Meningococcal Vaccination Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Meningococcal Vaccination Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Meningococcal Vaccination Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccination as of 2024)
Table 10. Global Market Meningococcal Vaccination Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Meningococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Meningococcal Vaccination Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Meningococcal Vaccination Sales by Type (K MT)
Table 26. Global Meningococcal Vaccination Market Size by Type (M USD)
Table 27. Global Meningococcal Vaccination Sales (K MT) by Type (2020-2025)
Table 28. Global Meningococcal Vaccination Sales Market Share by Type (2020-2025)
Table 29. Global Meningococcal Vaccination Market Size (M USD) by Type (2020-2025)
Table 30. Global Meningococcal Vaccination Market Size Share by Type (2020-2025)
Table 31. Global Meningococcal Vaccination Price (USD/KG) by Type (2020-2025)
Table 32. Global Meningococcal Vaccination Sales (K MT) by Application
Table 33. Global Meningococcal Vaccination Market Size by Application
Table 34. Global Meningococcal Vaccination Sales by Application (2020-2025) & (K MT)
Table 35. Global Meningococcal Vaccination Sales Market Share by Application (2020-2025)
Table 36. Global Meningococcal Vaccination Market Size by Application (2020-2025) & (M USD)
Table 37. Global Meningococcal Vaccination Market Share by Application (2020-2025)
Table 38. Global Meningococcal Vaccination Sales Growth Rate by Application (2020-2025)
Table 39. Global Meningococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 40. Global Meningococcal Vaccination Sales Market Share by Region (2020-2025)
Table 41. Global Meningococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 42. Global Meningococcal Vaccination Market Size Market Share by Region (2020-2025)
Table 43. North America Meningococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 44. North America Meningococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Meningococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 46. Europe Meningococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Meningococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Meningococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 49. South America Meningococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 50. South America Meningococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Meningococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Meningococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 53. Global Meningococcal Vaccination Production (K MT) by Region(2020-2025)
Table 54. Global Meningococcal Vaccination Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Meningococcal Vaccination Revenue Market Share by Region (2020-2025)
Table 56. Global Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Meningococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GlaxoSmithKline Basic Information
Table 62. GlaxoSmithKline Meningococcal Vaccination Product Overview
Table 63. GlaxoSmithKline Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline SWOT Analysis
Table 66. GlaxoSmithKline Recent Developments
Table 67. JN-International Medical Basic Information
Table 68. JN-International Medical Meningococcal Vaccination Product Overview
Table 69. JN-International Medical Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. JN-International Medical Business Overview
Table 71. JN-International Medical SWOT Analysis
Table 72. JN-International Medical Recent Developments
Table 73. Novartis International Basic Information
Table 74. Novartis International Meningococcal Vaccination Product Overview
Table 75. Novartis International Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Novartis International Business Overview
Table 77. Novartis International SWOT Analysis
Table 78. Novartis International Recent Developments
Table 79. Sanofi Basic Information
Table 80. Sanofi Meningococcal Vaccination Product Overview
Table 81. Sanofi Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Pfizer Basic Information
Table 85. Pfizer Meningococcal Vaccination Product Overview
Table 86. Pfizer Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Baxter International Basic Information
Table 90. Baxter International Meningococcal Vaccination Product Overview
Table 91. Baxter International Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Baxter International Business Overview
Table 93. Baxter International Recent Developments
Table 94. Biomed Basic Information
Table 95. Biomed Meningococcal Vaccination Product Overview
Table 96. Biomed Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Biomed Business Overview
Table 98. Biomed Recent Developments
Table 99. Serum Institute of India Basic Information
Table 100. Serum Institute of India Meningococcal Vaccination Product Overview
Table 101. Serum Institute of India Meningococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Serum Institute of India Business Overview
Table 103. Serum Institute of India Recent Developments
Table 104. Global Meningococcal Vaccination Sales Forecast by Region (2026-2033) & (K MT)
Table 105. Global Meningococcal Vaccination Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. North America Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (K MT)
Table 107. North America Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Europe Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (K MT)
Table 109. Europe Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Asia Pacific Meningococcal Vaccination Sales Forecast by Region (2026-2033) & (K MT)
Table 111. Asia Pacific Meningococcal Vaccination Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (K MT)
Table 113. South America Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Middle East and Africa Meningococcal Vaccination Sales Forecast by Country (2026-2033) & (Units)
Table 115. Middle East and Africa Meningococcal Vaccination Market Size Forecast by Country (2026-2033) & (M USD)
Table 116. Global Meningococcal Vaccination Sales Forecast by Type (2026-2033) & (K MT)
Table 117. Global Meningococcal Vaccination Market Size Forecast by Type (2026-2033) & (M USD)
Table 118. Global Meningococcal Vaccination Price Forecast by Type (2026-2033) & (USD/KG)
Table 119. Global Meningococcal Vaccination Sales (K MT) Forecast by Application (2026-2033)
Table 120. Global Meningococcal Vaccination Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Meningococcal Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccination Market Size (M USD), 2024-2033
Figure 5. Global Meningococcal Vaccination Market Size (M USD) (2020-2033)
Figure 6. Global Meningococcal Vaccination Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccination Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningococcal Vaccination Product Life Cycle
Figure 13. Meningococcal Vaccination Sales Share by Manufacturers in 2024
Figure 14. Global Meningococcal Vaccination Revenue Share by Manufacturers in 2024
Figure 15. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Meningococcal Vaccination Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccination Revenue in 2024
Figure 18. Industry Chain Map of Meningococcal Vaccination
Figure 19. Global Meningococcal Vaccination Market PEST Analysis
Figure 20. Global Meningococcal Vaccination Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Meningococcal Vaccination Market Share by Type
Figure 27. Sales Market Share of Meningococcal Vaccination by Type (2020-2025)
Figure 28. Sales Market Share of Meningococcal Vaccination by Type in 2024
Figure 29. Market Size Share of Meningococcal Vaccination by Type (2020-2025)
Figure 30. Market Size Share of Meningococcal Vaccination by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Meningococcal Vaccination Market Share by Application
Figure 33. Global Meningococcal Vaccination Sales Market Share by Application (2020-2025)
Figure 34. Global Meningococcal Vaccination Sales Market Share by Application in 2024
Figure 35. Global Meningococcal Vaccination Market Share by Application (2020-2025)
Figure 36. Global Meningococcal Vaccination Market Share by Application in 2024
Figure 37. Global Meningococcal Vaccination Sales Growth Rate by Application (2020-2025)
Figure 38. Global Meningococcal Vaccination Sales Market Share by Region (2020-2025)
Figure 39. Global Meningococcal Vaccination Market Size Market Share by Region (2020-2025)
Figure 40. North America Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Meningococcal Vaccination Sales Market Share by Country in 2024
Figure 43. North America Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Meningococcal Vaccination Market Size Market Share by Country in 2024
Figure 45. U.S. Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Meningococcal Vaccination Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Meningococcal Vaccination Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Meningococcal Vaccination Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Meningococcal Vaccination Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Meningococcal Vaccination Sales Market Share by Country in 2024
Figure 53. Europe Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Meningococcal Vaccination Market Size Market Share by Country in 2024
Figure 55. Germany Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Meningococcal Vaccination Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Meningococcal Vaccination Sales Market Share by Region in 2024
Figure 67. Asia Pacific Meningococcal Vaccination Market Size Market Share by Region in 2024
Figure 68. China Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Meningococcal Vaccination Sales and Growth Rate (K MT)
Figure 79. South America Meningococcal Vaccination Sales Market Share by Country in 2024
Figure 80. South America Meningococcal Vaccination Market Size and Growth Rate (M USD)
Figure 81. South America Meningococcal Vaccination Market Size Market Share by Country in 2024
Figure 82. Brazil Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Meningococcal Vaccination Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Meningococcal Vaccination Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Meningococcal Vaccination Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Meningococcal Vaccination Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Meningococcal Vaccination Production Market Share by Region (2020-2025)
Figure 103. North America Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 106. China Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Meningococcal Vaccination Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Meningococcal Vaccination Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Meningococcal Vaccination Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Meningococcal Vaccination Market Share Forecast by Type (2026-2033)
Figure 111. Global Meningococcal Vaccination Sales Forecast by Application (2026-2033)
Figure 112. Global Meningococcal Vaccination Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Meningococcal Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccination Market Size (M USD), 2024-2033
Figure 5. Global Meningococcal Vaccination Market Size (M USD) (2020-2033)
Figure 6. Global Meningococcal Vaccination Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccination Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningococcal Vaccination Product Life Cycle
Figure 13. Meningococcal Vaccination Sales Share by Manufacturers in 2024
Figure 14. Global Meningococcal Vaccination Revenue Share by Manufacturers in 2024
Figure 15. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Meningococcal Vaccination Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccination Revenue in 2024
Figure 18. Industry Chain Map of Meningococcal Vaccination
Figure 19. Global Meningococcal Vaccination Market PEST Analysis
Figure 20. Global Meningococcal Vaccination Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Meningococcal Vaccination Market Share by Type
Figure 27. Sales Market Share of Meningococcal Vaccination by Type (2020-2025)
Figure 28. Sales Market Share of Meningococcal Vaccination by Type in 2024
Figure 29. Market Size Share of Meningococcal Vaccination by Type (2020-2025)
Figure 30. Market Size Share of Meningococcal Vaccination by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Meningococcal Vaccination Market Share by Application
Figure 33. Global Meningococcal Vaccination Sales Market Share by Application (2020-2025)
Figure 34. Global Meningococcal Vaccination Sales Market Share by Application in 2024
Figure 35. Global Meningococcal Vaccination Market Share by Application (2020-2025)
Figure 36. Global Meningococcal Vaccination Market Share by Application in 2024
Figure 37. Global Meningococcal Vaccination Sales Growth Rate by Application (2020-2025)
Figure 38. Global Meningococcal Vaccination Sales Market Share by Region (2020-2025)
Figure 39. Global Meningococcal Vaccination Market Size Market Share by Region (2020-2025)
Figure 40. North America Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Meningococcal Vaccination Sales Market Share by Country in 2024
Figure 43. North America Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Meningococcal Vaccination Market Size Market Share by Country in 2024
Figure 45. U.S. Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Meningococcal Vaccination Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Meningococcal Vaccination Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Meningococcal Vaccination Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Meningococcal Vaccination Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Meningococcal Vaccination Sales Market Share by Country in 2024
Figure 53. Europe Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Meningococcal Vaccination Market Size Market Share by Country in 2024
Figure 55. Germany Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Meningococcal Vaccination Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Meningococcal Vaccination Sales Market Share by Region in 2024
Figure 67. Asia Pacific Meningococcal Vaccination Market Size Market Share by Region in 2024
Figure 68. China Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Meningococcal Vaccination Sales and Growth Rate (K MT)
Figure 79. South America Meningococcal Vaccination Sales Market Share by Country in 2024
Figure 80. South America Meningococcal Vaccination Market Size and Growth Rate (M USD)
Figure 81. South America Meningococcal Vaccination Market Size Market Share by Country in 2024
Figure 82. Brazil Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Meningococcal Vaccination Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Meningococcal Vaccination Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Meningococcal Vaccination Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Meningococcal Vaccination Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Meningococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Meningococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Meningococcal Vaccination Production Market Share by Region (2020-2025)
Figure 103. North America Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 106. China Meningococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Meningococcal Vaccination Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Meningococcal Vaccination Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Meningococcal Vaccination Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Meningococcal Vaccination Market Share Forecast by Type (2026-2033)
Figure 111. Global Meningococcal Vaccination Sales Forecast by Application (2026-2033)
Figure 112. Global Meningococcal Vaccination Market Share Forecast by Application (2026-2033)
